OCDX - Ortho Clinical Diagnostics Faces Uncertain Merger And Inflation Environment

• Ortho Clinical Diagnostics went public in January 2021, raising $1.3 billion in gross proceeds in an IPO.
• The firm provides diagnostics services primarily to hospital labs in the U.S.
• With the acquisition deal potentially on approval hold and Quidel’s sharp stock price drop, the near-term future for OCDX is highly uncertain.

For further details see: